Cytek Biosciences, Inc. (CTKB)
NASDAQ: CTKB · Real-Time Price · USD
4.320
-0.260 (-5.68%)
At close: Mar 27, 2026, 4:00 PM EDT
4.370
+0.050 (1.16%)
After-hours: Mar 27, 2026, 5:32 PM EDT
Cytek Biosciences Revenue
In the year 2025, Cytek Biosciences had annual revenue of $201.49M with 0.52% growth. Cytek Biosciences had revenue of $62.14M in the quarter ending December 31, 2025, with 8.12% growth.
Revenue (ttm)
$201.49M
Revenue Growth
+0.52%
P/S Ratio
2.76
Revenue / Employee
$287,027
Employees
702
Market Cap
555.34M
Revenue Chart
Revenue History
| Fiscal Year End | Revenue | Change | Growth |
|---|---|---|---|
| Dec 31, 2025 | 201.49M | 1.04M | 0.52% |
| Dec 31, 2024 | 200.45M | 7.44M | 3.85% |
| Dec 31, 2023 | 193.02M | 28.98M | 17.67% |
| Dec 31, 2022 | 164.04M | 36.09M | 28.20% |
| Dec 31, 2021 | 127.95M | 35.11M | 37.82% |
| Dec 31, 2020 | 92.84M | 34.96M | 60.39% |
| Dec 31, 2019 | 57.88M | - | - |
Revenue Definition
Revenue, also called sales, is the amount of money a company receives from its business activities, such as sales of products or services. Revenue does not take any expenses into account and is therefore different from profits.
Full DefinitionRelated Stocks
| Company Name | Revenue |
|---|---|
| Integra LifeSciences Holdings | 1.64B |
| Lumexa Imaging Holdings | 1.02B |
| Orthofix Medical | 822.31M |
| Avanos Medical | 701.20M |
| Bioventus | 568.09M |
| Tactile Systems Technology | 329.52M |
| Axogen | 225.21M |
| SI-BONE | 200.93M |
CTKB News
- 20 days ago - Cytek® Biosciences Celebrates One Year of Operations at Singapore Facility, Accelerating Growth and Regional Impact - GlobeNewsWire
- 4 weeks ago - Cytek Biosciences, Inc. (CTKB) Q4 2025 Earnings Call Transcript - Seeking Alpha
- 4 weeks ago - Cytek Biosciences Reports Fourth Quarter and Full Year 2025 Financial Results and Provides 2026 Outlook - GlobeNewsWire
- 5 weeks ago - Cytek Biosciences to participate at the TD Cowen 46th Annual Health Care Conference - GlobeNewsWire
- 6 weeks ago - Cytek Biosciences to Report Fourth Quarter and Full Year 2025 Financial Results on February 26, 2026 - GlobeNewsWire
- 2 months ago - Cytek Biosciences, Inc. (CTKB) Presents at 44th Annual J.P. Morgan Healthcare Conference Transcript - Seeking Alpha
- 2 months ago - Cytek Biosciences Announces Preliminary Fourth Quarter and Full Year 2025 Revenue Results - GlobeNewsWire
- 4 months ago - Cytek Biosciences Is A Speculative Buy On Recurring Revenue Growth - Seeking Alpha